The Royal College of Ophthalmologists is pleased to publish revised guidance on the treatment of Retinopathy of prematurity (ROP). ROP is a potentially blinding condition affecting low gestation and very low birth weight infants. Worldwide, it is a major cause of preventable blindness.
Screening for ROP is undertaken to identify ROP that requires treatment. This evidence-based guideline for the treatment of ROP was developed by a multidisciplinary guideline development group (GDG) led by Miss Gill Adams (Moorfields Eye hospital) on behalf of The Royal College of Ophthalmologists (RCOphth) and included contributions from the UK special interest group of ROP screeners and treaters (ROP-SIG) and representatives from the Royal College of Paediatrics and Child Health (RCPCH) and the Bliss charity.
The guideline was produced according to RCOphth standards for guideline development and has NICE accreditation. It is published on the same day as a revised guideline on Screening for ROP published by RCPCH.